方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| CHA₂DS₂-VASc 评分× | CURB-65肺炎严重程度评分× | |
|---|---|---|
| 领域 | 临床评估 | 临床评估 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2010 | 2003 |
| 提出者≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | W. Staniford Lim, et al. |
| 类型≠ | Atrial fibrillation stroke risk stratification | Community-acquired pneumonia severity assessment |
| 开创性文献≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382. DOI ↗ |
| 别名 | CHA2DS2VASc, Atrial fibrillation stroke risk | CURB-65, Pneumonia severity |
| 相关 | 3 | 3 |
| 摘要≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions. |
| ScholarGate数据集 ↗ |
|
|